WEAR - Search Results
GlaxoSmithKline to pay multi-million dollar settlement
Drugmaker GlaxoSmithKline PLC will pay $105 million to dozens of states including Florida and Alabama.
The payment comes to settle allegations that it marketed drugs for uses unapproved by federal regulators. Lawsuits filed in 44 states and the District of Columbia alleged the British Drugmaker misrepresented the uses and qualities of its asthma drug Advair and the antidepressants Paxil and Wellbutrin.
GlaxoSmithKline settled a similar case with the federal government two years ago for a record $3 billion. Its marketing practices also are under investigation in Britain, China, and several other countries.